Pallav L. Shah

Apr 18, 2024 | resmedjournal.com | T. David Koster |Pallav L. Shah |Arschang Valipour |Klinik Floridsdorf |Gerard J. Criner |Felix J.F. Herth | +9 more

Endobronchial Valve Therapy in Patients with Homogeneous Emphysema. Results from the IMPACT Study. Am J Respir Crit Care Med. 2016; 194: 1073-1082Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation. N Engl J Med. 2015; 373: 2325-2335A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM). Am J Respir Crit Care Med.

Apr 4, 2024 | thorax.bmj.com | Pallav L. Shah

Ablation for lung cancer: hot or cold intervention Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Mar 15, 2024 | thorax.bmj.com | Pieta Wijsman |Thais Mauad |Pallav L. Shah |Jouke T. Annema

Airway smooth muscle and long-term clinical efficacy following bronchial thermoplasty in severe asthma Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Feb 12, 2024 | thorax.bmj.com | Pieta Wijsman |Thais Mauad |Pallav L. Shah |Jouke T. Annema

DiscussionTo the best of our knowledge, this study is the first study that investigated the 2.5-year impact of BT on clinical outcomes and ASM by paired data analysis. Our findings demonstrate persistent clinical efficacy coincided with a reduction in the ASM mass until 2.5 years after-BT as compared with baseline.